Bone TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationBone Marrow TransplantationGraft vs Host DiseaseBone and BonesTransplantation ConditioningTissue DonorsTransplantation, AutologousGraft SurvivalKidney TransplantationHematologic NeoplasmsGraft vs Tumor EffectHistocompatibility TestingLeukemiaGraft RejectionBone RemodelingTransplantsTreatment OutcomeRecurrenceBusulfanWhole-Body IrradiationImmunosuppressive AgentsRetrospective StudiesBone DensityTime FactorsHeart TransplantationRemission InductionLeukemia, Myeloid, AcuteSurvival AnalysisBone MarrowTransplantationBone ResorptionBone Marrow CellsGranulocyte Colony-Stimulating FactorLung TransplantationCombined Modality TherapySurvival RateDisease-Free SurvivalImmunosuppressionCyclosporineBone NeoplasmsBone DevelopmentTissue and Organ ProcurementBone DiseasesTacrolimusTransplantation ImmunologyCytomegalovirus InfectionsLiving DonorsTransplantation ChimeraPostoperative ComplicationsHistocompatibilityTransplantation, IsogeneicWaiting ListsIsoantigensT-LymphocytesStem Cell TransplantationFetal Tissue TransplantationBone RegenerationImmunocompromised HostBone MatrixLymphocyte Culture Test, MixedMycophenolic AcidTransplantation ToleranceFollow-Up StudiesMice, Inbred C57BLCadaverSkin TransplantationHLA AntigensKidney Failure, ChronicRisk FactorsAcute DiseaseLiver FailureTransplantation, HeterotopicAntilymphocyte SerumCytomegalovirusGraft vs Leukemia EffectMice, Inbred BALB CIsoantibodiesAnemia, AplasticOpportunistic InfectionsBone Diseases, MetabolicGanciclovirLymphocyte DepletionIslets of Langerhans TransplantationFractures, BoneBone SubstitutesHeart-Lung TransplantationGraft vs Host ReactionProspective StudiesPeripheral Blood Stem Cell TransplantationBrain Tissue TransplantationLymphoproliferative DisordersLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte ActivationBronchiolitis ObliteransHematopoietic Stem CellsRadiation ChimeraPrecursor Cell Lymphoblastic Leukemia-LymphomaMyeloablative Agonists